scispace - formally typeset
I

Ildikó Gágyor

Researcher at University of Göttingen

Publications -  68
Citations -  1341

Ildikó Gágyor is an academic researcher from University of Göttingen. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 13, co-authored 38 publications receiving 1075 citations. Previous affiliations of Ildikó Gágyor include University of Toronto & University of Würzburg.

Papers
More filters
Journal ArticleDOI

Corticosteroids for Bell's palsy (idiopathic facial paralysis)

TL;DR: The available moderate- to high-quality evidence from randomised controlled trials showed significant benefit from treating Bell's palsy with corticosteroids, and this Cochrane systematic review deemed the larger studies at low risk of bias.
Journal ArticleDOI

Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial

TL;DR: Initial symptomatic treatment with ibuprofen is a possible approach to be discussed with women willing to avoid immediate antibiotics and to accept a somewhat higher burden of symptoms.
Journal ArticleDOI

Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - Results of a randomized controlled pilot trial

TL;DR: The results support the assumption of non-inferiority of ibuprofen compared to ciprofloxacin for treatment of symptomatic uncomplicated UTI, but need confirmation by further trials.
Journal ArticleDOI

Antiviral treatment for Bell's palsy (idiopathic facial paralysis)

TL;DR: A significant benefit is found from adding antivirals to corticosteroids in comparison with cortiosteroids alone for people with Bell's palsy and a reduction in the rate of incomplete recovery at month six is found.
Journal ArticleDOI

Resistance profiles of urinary tract infections in general practice - an observational study

TL;DR: Resistance rates of uropathogens from unselected patients in general practice differ from routinely collected laboratory data, which can have an impact on antibiotic prescribing and treatment recommendations.